Todd Townsend is an experienced regulatory scientist and pharmacologist with over a decade of direct experience as an academic biomedical researcher, clinical researcher and consultant in the fields of epigenetics, cardiology, immunology, inflammation, oncology and bioinformatics. Todd is currently a Commissioner’s Fellow with the U.S. FDA, where his recent work involves bridging existing resources and developing new technologies to streamline and accelerate numerous aspects of clinical development and safety hazard assessment pipelines. Todd also advises on best practices for delivering positive health outcomes to patients; aligning payer, industry and regulatory business and data-sharing initiatives via novel strategies and patient-centric policies.